Baltimore may receive much less than it was hoping from its trial against opioid distributors McKesson and AmerisourceBergen after a ruling from Maryland Circuit Court Judge Lawerence Fletcher-Hill last Friday.

Fletcher-Hill ruled that Baltimore is due $100 million in abatement funds from the companies to rectify future issues caused by the widespread sale and distribution of opioids over the last two decades.

The decision is significantly less than the more than $5 billion the city requested for abatement in its more than 90-page plan spelling out what needs to be done to reduce overdoses and stem addiction in the city.

Read more at WYPR.

See Full Page